When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
出版年份 2013 全文链接
标题
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 7, Pages e69462
出版商
Public Library of Science (PLoS)
发表日期
2013-07-09
DOI
10.1371/journal.pone.0069462
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Healthy Men Should Not Take Statins
- (2012) Mitchell H. Katz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
- (2012) Antonis Valachis et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins for people at low risk of cardiovascular disease
- (2012) Alessandro Battaggia et al. LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) William G Simpson LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) Nicholas Wald et al. LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) Ella Zomer et al. LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) Luca Mascitelli et al. LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) David H Newman et al. LANCET
- Statins for people at low risk of cardiovascular disease
- (2012) Alberto Donzelli LANCET
- Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis
- (2012) Ferrán Catalá-López et al. PLoS One
- Promoting Transparency in Pharmaceutical Industry–Sponsored Research
- (2011) Joseph S. Ross et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- A glimpse into the black box of cost-effectiveness analyses
- (2011) A. A. John-Baptiste et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
- (2011) N. P. Polyzos et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era
- (2011) Lawrence D. Lazar et al. CIRCULATION
- Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
- (2011) Piia K. Peura et al. MEDICAL DECISION MAKING
- Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
- (2010) Sekwon Jang et al. BREAST CANCER RESEARCH AND TREATMENT
- Modeling in pharmacoeconomic studies: Funding sources and outcomes
- (2010) Livio Garattini et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- A Bibliometric Review of Cost-Effectiveness Analyses in the Economic and Medical Literature: 1976-2006
- (2010) Dan Greenberg et al. MEDICAL DECISION MAKING
- Does the Funding Source Influence the Results in Economic Evaluations?
- (2010) Rachael L. Fleurence et al. PHARMACOECONOMICS
- Transparency of Economic Evaluations of Health Technologies
- (2009) Joan Rovira PHARMACOECONOMICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now